MA50438A - Promédicaments de dérivés de triazole substitués, et utilisations de ceux-ci - Google Patents

Promédicaments de dérivés de triazole substitués, et utilisations de ceux-ci

Info

Publication number
MA50438A
MA50438A MA050438A MA50438A MA50438A MA 50438 A MA50438 A MA 50438A MA 050438 A MA050438 A MA 050438A MA 50438 A MA50438 A MA 50438A MA 50438 A MA50438 A MA 50438A
Authority
MA
Morocco
Prior art keywords
triazole derivatives
substituted triazole
substituted
derivatives
triazole
Prior art date
Application number
MA050438A
Other languages
English (en)
Other versions
MA50438B1 (fr
Inventor
Anja Buchmueller
Hana Cernecka
Marie-Pierre Collin-Kroepelin
Karoline Droebner
Robert Fricke
Chantal Fuerstner
Peter Kolkhof
Ursula Krenz
Axel Kretschmer
Guillaume Levilain
Klemens Lustig
Thomas Mondritzki
Thomas Neubauer
Elisabeth Pook
Heiko Schirmer
Carsten Schmeck
Hanna Tinel
Pierre Wasnaire
Norbert Witowski
Matthias Beat Wittwer
Original Assignee
Bayer Ag
Bayer Pharma AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag, Bayer Pharma AG filed Critical Bayer Ag
Publication of MA50438A publication Critical patent/MA50438A/fr
Publication of MA50438B1 publication Critical patent/MA50438B1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
    • C07F9/65583—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system each of the hetero rings containing nitrogen as ring hetero atom
MA50438A 2017-10-24 2018-10-17 Promédicaments de dérivés de triazole substitués, et utilisations de ceux-ci MA50438B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP17197935 2017-10-24
PCT/EP2018/078364 WO2019081292A1 (fr) 2017-10-24 2018-10-17 Promédicaments de dérivés de triazole substitués, et utilisations de ceux-ci

Publications (2)

Publication Number Publication Date
MA50438A true MA50438A (fr) 2020-09-02
MA50438B1 MA50438B1 (fr) 2022-03-31

Family

ID=60162099

Family Applications (1)

Application Number Title Priority Date Filing Date
MA50438A MA50438B1 (fr) 2017-10-24 2018-10-17 Promédicaments de dérivés de triazole substitués, et utilisations de ceux-ci

Country Status (38)

Country Link
US (1) US11298367B2 (fr)
EP (1) EP3700913B1 (fr)
JP (1) JP2021500365A (fr)
KR (1) KR20200069361A (fr)
CN (1) CN111225921A (fr)
AR (1) AR113791A1 (fr)
AU (1) AU2018356352A1 (fr)
BR (1) BR112020007983A2 (fr)
CA (1) CA3079767A1 (fr)
CL (1) CL2020001076A1 (fr)
CO (1) CO2020004945A2 (fr)
CR (1) CR20200176A (fr)
CU (1) CU24604B1 (fr)
CY (1) CY1124938T1 (fr)
DK (1) DK3700913T3 (fr)
DO (1) DOP2020000076A (fr)
EA (1) EA202091025A1 (fr)
EC (1) ECSP20023056A (fr)
ES (1) ES2906305T3 (fr)
HR (1) HRP20220060T1 (fr)
HU (1) HUE057278T2 (fr)
IL (1) IL273949A (fr)
JO (1) JOP20200099A1 (fr)
LT (1) LT3700913T (fr)
MA (1) MA50438B1 (fr)
MX (1) MX2020004191A (fr)
NI (1) NI202000030A (fr)
PE (1) PE20210394A1 (fr)
PH (1) PH12020550473A1 (fr)
PL (1) PL3700913T3 (fr)
PT (1) PT3700913T (fr)
RS (1) RS62984B1 (fr)
SG (1) SG11202003049WA (fr)
SI (1) SI3700913T1 (fr)
TW (1) TW201932117A (fr)
UA (1) UA126456C2 (fr)
UY (1) UY37948A (fr)
WO (1) WO2019081292A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021259852A1 (fr) 2020-06-25 2021-12-30 Bayer Aktiengesellschaft Procédé de préparation de dérivés de 5-(alcoxycarbonyle)-et de 5- (carboxamide)-1-aryl-1,2,4-triazole
WO2022112213A1 (fr) 2020-11-30 2022-06-02 Bayer Aktiengesellschaft Formes cristallines de 3-[[3-(4-chlorophényl)-5-oxo-4-((2s)-3,3,3-trifluoro-2-hydroxypropyl)-4,5-dihydro-1h-1,2,4-triazol-1-yl]méthyl]-1-[3- (trifluorométhyl)pyridin-2-yl]-1h-1,2,4-triazole-5-carboxamide

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3966781A (en) 1970-12-17 1976-06-29 Merck Sharp & Dohme (I.A.) Corporation Deuteration of functional group-containing hydrocarbons
DE19834044A1 (de) 1998-07-29 2000-02-03 Bayer Ag Neue substituierte Pyrazolderivate
DE19834047A1 (de) 1998-07-29 2000-02-03 Bayer Ag Substituierte Pyrazolderivate
DE19943635A1 (de) 1999-09-13 2001-03-15 Bayer Ag Neuartige Aminodicarbonsäurederivate mit pharmazeutischen Eigenschaften
DE19943639A1 (de) 1999-09-13 2001-03-15 Bayer Ag Dicarbonsäurederivate mit neuartigen pharmazeutischen Eigenschaften
DE19943636A1 (de) 1999-09-13 2001-03-15 Bayer Ag Neuartige Dicarbonsäurederivate mit pharmazeutischen Eigenschaften
DE19943634A1 (de) 1999-09-13 2001-04-12 Bayer Ag Neuartige Dicarbonsäurederivate mit pharmazeutischen Eigenschaften
AR031176A1 (es) 2000-11-22 2003-09-10 Bayer Ag Nuevos derivados de pirazolpiridina sustituidos con piridina
DE10110750A1 (de) 2001-03-07 2002-09-12 Bayer Ag Neuartige Aminodicarbonsäurederivate mit pharmazeutischen Eigenschaften
DE10110749A1 (de) 2001-03-07 2002-09-12 Bayer Ag Substituierte Aminodicarbonsäurederivate
DE10220570A1 (de) 2002-05-08 2003-11-20 Bayer Ag Carbamat-substituierte Pyrazolopyridine
KR100854872B1 (ko) 2003-12-22 2008-08-28 화이자 인코포레이티드 바소프레신 길항제로서의 트리아졸 유도체
WO2005105779A1 (fr) 2004-04-28 2005-11-10 Pfizer Limited Derives 3-heterocyclyl-4-phenyl-triazole comme inhibiteurs de la vasopressine par recepteur
JP2011502982A (ja) * 2007-11-06 2011-01-27 アストラゼネカ・アクチエボラーグ 好中球エラスターゼの阻害剤としてのある種の２−ピラジノン誘導体およびその使用
DE102010001064A1 (de) 2009-03-18 2010-09-23 Bayer Schering Pharma Aktiengesellschaft Substituierte 2-Acetamido-5-Aryl-1,2,4-triazolone und deren Verwendung
AR076542A1 (es) * 2009-05-22 2011-06-22 Merck Sharp & Dohme Antagonistas del receptor de orexina de isonicotinamida
AU2011219746B2 (en) 2010-02-27 2015-04-23 Bayer Intellectual Property Gmbh Bisaryl-bonded aryltriazolones and use thereof
DE102010021637A1 (de) 2010-05-26 2011-12-01 Bayer Schering Pharma Aktiengesellschaft Substituierte 5-Fluor-1H-Pyrazolopyridine und ihre Verwendung
CN106977530A (zh) 2010-07-09 2017-07-25 拜耳知识产权有限责任公司 环稠合的嘧啶和三嗪以及其用于治疗和/或预防心血管疾病的用途
DE102010040233A1 (de) 2010-09-03 2012-03-08 Bayer Schering Pharma Aktiengesellschaft Bicyclische Aza-Heterocyclen und ihre Verwendung
DE102010043379A1 (de) 2010-11-04 2012-05-10 Bayer Schering Pharma Aktiengesellschaft Substituierte 6-Fluor-1H-Pyrazolo[4,3-b]pyridine und ihre Verwendung
US8791162B2 (en) 2011-02-14 2014-07-29 Merck Sharp & Dohme Corp. Cathepsin cysteine protease inhibitors
MX2016004532A (es) * 2013-10-16 2016-07-22 Bayer Cropscience Ag Combinaciones de compuestos activos que comprenden un derivado de (tio)carboxamida y un compuesto fungicida.
CN107074783B (zh) 2014-11-03 2020-06-05 拜耳制药股份公司 羟烷基取代的苯基三唑衍生物及其用途
UY36571A (es) * 2015-03-05 2016-09-30 Bayer Cropscience Ag Combinaciones de compuestos activos
AR108265A1 (es) 2016-05-03 2018-08-01 Bayer Pharma AG Derivados de feniltriazol sustituidos con amida y usos de estos
US9988367B2 (en) 2016-05-03 2018-06-05 Bayer Pharma Aktiengesellschaft Amide-substituted pyridinyltriazole derivatives and uses thereof
WO2017191114A1 (fr) 2016-05-03 2017-11-09 Bayer Aktiengesellschaft Dérivés d'hétéroaryltriazole substitués par hydroxyalkyle et utilisations associées
WO2017191105A1 (fr) 2016-05-03 2017-11-09 Bayer Pharma Aktiengesellschaft Dérivés d'aryltriazole à substitution amide et leurs utilisations
EP3452457B1 (fr) 2016-05-03 2020-03-18 Bayer Pharma Aktiengesellschaft Dérivés de phényltriazole à substitution oxoalkyle et utilisations associées
US10525041B2 (en) 2016-05-03 2020-01-07 Bayer Pharma Aktiengesellschaft Fluoroalkyl-substituted aryltriazole derivatives and uses thereof
WO2018073144A1 (fr) 2016-10-20 2018-04-26 Bayer Pharma Aktiengesellschaft Dérivés de triazole substitués par hydroxyalkyle et utilisations associées

Also Published As

Publication number Publication date
EP3700913B1 (fr) 2021-11-10
CN111225921A (zh) 2020-06-02
CU20200040A7 (es) 2021-03-11
DK3700913T3 (da) 2022-02-07
LT3700913T (lt) 2022-01-25
JP2021500365A (ja) 2021-01-07
PE20210394A1 (es) 2021-03-02
UA126456C2 (uk) 2022-10-05
AU2018356352A1 (en) 2020-04-16
ES2906305T3 (es) 2022-04-18
MX2020004191A (es) 2020-08-03
WO2019081292A1 (fr) 2019-05-02
UY37948A (es) 2019-05-31
BR112020007983A2 (pt) 2020-10-27
AR113791A1 (es) 2020-06-10
US20200338096A1 (en) 2020-10-29
CO2020004945A2 (es) 2020-05-05
PL3700913T3 (pl) 2022-02-21
PH12020550473A1 (en) 2021-03-08
PT3700913T (pt) 2022-01-31
US11298367B2 (en) 2022-04-12
NI202000030A (es) 2020-10-09
CR20200176A (es) 2020-07-24
SI3700913T1 (sl) 2022-02-28
CL2020001076A1 (es) 2021-02-19
CA3079767A1 (fr) 2019-05-02
SG11202003049WA (en) 2020-04-29
DOP2020000076A (es) 2020-08-31
TW201932117A (zh) 2019-08-16
HRP20220060T1 (hr) 2022-04-15
CU24604B1 (es) 2022-06-06
EA202091025A1 (ru) 2020-07-30
RS62984B1 (sr) 2022-03-31
IL273949A (en) 2020-05-31
ECSP20023056A (es) 2020-12-31
HUE057278T2 (hu) 2022-04-28
MA50438B1 (fr) 2022-03-31
JOP20200099A1 (ar) 2020-05-06
EP3700913A1 (fr) 2020-09-02
CY1124938T1 (el) 2023-01-05
KR20200069361A (ko) 2020-06-16

Similar Documents

Publication Publication Date Title
MA50256A (fr) Composés de pyrazolopyrimidinone et leurs utilisations
MA52483A (fr) Dérivés de gip et leurs utilisations
MA42599A (fr) Dérivés de triazole, leurs intermédiaires et leur utilisation comme fongicides
MA50618A (fr) Polyrhérapies et leurs utilisations
DK3676297T3 (da) Forbindelser, sammensætninger og fremgangsmåder
DK3297637T3 (da) Benzen-1,3,5-tricarboxamidderivater og anvendelser deraf
MA43821A (fr) Pyrimidines et variantes de celles-ci, et leurs utilisations
DK3253762T3 (da) 9h-pyrrolo-dipyridinderivater.
MA44489A (fr) Pyrimidines et variants de celles-ci, et leurs utilisations
MA45857A (fr) Composés et compositions, et utilisations associées
MA50413A (fr) Dérivés de benzimidazole et leurs utilisations
MA52411A (fr) Dérivés de 2,4-diaminoquinazoline et leurs utilisations médicales
DK3805513T3 (da) Rulledør
MA41495A (fr) Composés benzoxaborole et leurs utilisations
MA45795A (fr) Composés et compositions, et utilisations associées
MA52977A (fr) Composés de cyanotriazole et leurs utilisations
MA50438A (fr) Promédicaments de dérivés de triazole substitués, et utilisations de ceux-ci
DK3070964T3 (da) Høreapparat, især hørehjælpeapparat.
DK3645513T3 (da) Benzazepinderivater
DK3428195T3 (da) Modificeret stivelse
IT201700055726A1 (it) Porta scorrevole.
MA41641A (fr) Dérivés de tétrahydropyranylbenzamide
MA51126A (fr) Dérivés de 2-oxo-1-pyrrolidinyl imidazothiadiazole
DK3642202T3 (da) Dihydro-pyrrolo-pyridin-derivater
IT201700094491A1 (it) Reattore.